📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. (2023)

First Author: Brocklebank V

Attributed to: Personalised management of atypical haemolytic uraemic syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022018833

PubMed Identifier: 37369098

Publication URI: http://europepmc.org/abstract/MED/37369098

Type: Journal Article/Review

Volume: 142

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971